Search by Drug Name or NDC
NDC 82009-0030-10 Duloxetine 30 mg/1 Details
Duloxetine 30 mg/1
Duloxetine is a ORAL CAPSULE, DELAYED RELEASE PELLETS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quallent Pharmaceuticals Health, LLC. The primary component is DULOXETINE HYDROCHLORIDE.
Product Information
| NDC | 82009-0030 |
|---|---|
| Product ID | 82009-030_c6042c04-f7be-4ee0-b09a-171ea47adf51 |
| Associated GPIs | |
| GCN Sequence Number | 057892 |
| GCN Sequence Number Description | duloxetine HCl CAPSULE DR 30 MG ORAL |
| HIC3 | H7C |
| HIC3 Description | SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS) |
| GCN | 23162 |
| HICL Sequence Number | 026521 |
| HICL Sequence Number Description | DULOXETINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Duloxetine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DULOXETINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, DELAYED RELEASE PELLETS |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | DULOXETINE HYDROCHLORIDE |
| Labeler Name | Quallent Pharmaceuticals Health, LLC |
| Pharmaceutical Class | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203088 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 82009-0030-10 (82009003010)
| NDC Package Code | 82009-030-10 |
|---|---|
| Billing NDC | 82009003010 |
| Package | 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-030-10) |
| Marketing Start Date | 2022-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.09367 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DULOXETINE HCL DR 30 MG CAP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis